2413603-15-1

2413603-15-1 structure
2413603-15-1 structure
  • Name: HDAC6-IN-5
  • Chemical Name: HDAC6-IN-5
  • CAS Number: 2413603-15-1
  • Molecular Formula: C20H14BrN3O2
  • Molecular Weight: 408.25
  • Catalog: Signaling Pathways Cell Cycle/DNA Damage HDAC
  • Create Date: 2022-07-01 11:59:41
  • Modify Date: 2024-01-09 13:10:02
  • HDAC6-IN-5 (compound 11b) is a potent and BBB-penetrated HDAC6 inhibitor, with an IC50 of 0.025 μM. HDAC6-IN-5 exhibits strong inhibitory activity against Aβ1-42 self-aggregation and AChE, with IC50 values of 3.0 and 0.72 μM. HDAC6-IN-5 can enhance neurite outgrowth without significant neurotoxicity[1].

Name HDAC6-IN-5
Description HDAC6-IN-5 (compound 11b) is a potent and BBB-penetrated HDAC6 inhibitor, with an IC50 of 0.025 μM. HDAC6-IN-5 exhibits strong inhibitory activity against Aβ1-42 self-aggregation and AChE, with IC50 values of 3.0 and 0.72 μM. HDAC6-IN-5 can enhance neurite outgrowth without significant neurotoxicity[1].
Related Catalog
Target

HDAC6:0.026 ± 0. μM (IC50)

HDAC1:0.09 ± 0.0 μM (IC50)

HDAC:0.16 ± 0.0 μM (IC50)

HDAC3:0.33 ± 0. μM (IC50)

HDAC2:0.48 ± 0.0 μM (IC50)

HDAC9:5.51 ± 0.0 μM (IC50)

HDAC5:7.19 ± 0.4 μM (IC50)

HDAC4:7.85 ± 0.6 μM (IC50)

HDAC7:9.13 ± 0.3 μM (IC50)

In Vitro HDAC6-IN-5 (compound 11b) induces histone H3 and α-tubulin acetylation in a dose-dependent manner, with EC50 values of 0.58 and 8 μM, respectively[1]
References

[1]. Tseng HJ, et al. Synthesis and biological evaluation of acridine-based histone deacetylase inhibitors as multitarget agents against Alzheimer's disease. Eur J Med Chem. 2020 Apr 15;192:112193.

Molecular Formula C20H14BrN3O2
Molecular Weight 408.25